Robinhood Markets, Inc.’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
Other funds holding CHRS
TGY2IT
CM
Robinhood Markets, Inc.'s CHRS Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in Coherus Oncology (CHRS) in Q3 2026: 29 shares worth $36. The stake represents ﹤0.01% of the portfolio and ranks #1273 among its holdings.
136 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.
- Robinhood Markets, Inc. held 29 shares of Coherus Oncology worth $36 as of Q3 2026.
- Coherus Oncology was a new Robinhood Markets, Inc. position in Q3 2026.
- Coherus Oncology made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1273 holding.
- 136 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.